Company Profile
Updated: 17-SEP-09Atrium Corp.
Private Company, Headquarters Location
PO Box 226957, Dallas, TX 75222-6957, United States
(800)421-6292, (214)630-5757, (214)951-0642 fax, http://www.atriumcompanies.org
Primary SIC: Metal Doors, Sash And Trim, Primary NAICS: Metal Window and Door Manufacturing
Description: Manufacturing: Aluminum and vinyl doors and windows; wood products.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
United States: Bids for Public Housing Modernization - Phase 1.
TendersInfo; 11/14/2009; 531 words; ...copies of the Bidding Documents may be obtained from Docunet Corp. located at 2435 Xenium Lane North, Plymouth, MN 55441...requirements on December 8, 2009. Meet in the Community Room at the Atrium Building at 10:00 a.m. Bid security in the amount of 5...
United States : Corporate investments nearly $1B over past 2 years in Middletown.
TendersInfo; 11/5/2009; 880 words; ...stimulus money funding and is yet one more reason why AK Steel Corp. is a valuable community asset. It also shows that AK is making...projects, the city also boasts investments topping $265 from Atrium Medical Center and a $20 million expansion by Quaker Chemical...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1647 words; ...its agreement with Edwards Lifesciences Corp., of Irvine, Calif., regarding the...as outlined in the original agreement. o Atrium Biotechnologies Inc., of Quebec, changed its name to Atrium Innovations Inc. The company said the name...
FDA To Cardiome: More Data Needed To Clear Oxypurinol.
BIOWORLD Today; 11/3/2009; 976 words; Washington Editor Cardiome Pharma Corp.'s stock held steady Thursday after the company reported that...administration treatment for atrial fibrillation, a condition in which the atria of the heart beat rapidly and erratically. The intravenous candidate...
Genzyme, Inamed Receive Approval For Dermal Filler.
BIOWORLD Today; 11/3/2009; 1076 words; Washington Editor Genzyme Corp. and its exclusive worldwide partner, Inamed Corp., won FDA approval to market Hylaform gel...verdict in a patent infringement lawsuit against Atrium Medical Corp., of Hudson, N.H. A statement released...
Recent News Articles
- Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent.
PR Newswire - June 09, 2008 - Hudson med-tech manufacturer strives to improve lives: Atrium Medical Corp. flourishes by focusing on patients, employees, community.(Company overview)
New Hampshire Business Review - February 02, 2007 - Atrium Medical Corporation Receives FDA Approval for the iVENA(TM) Vascular Patch.
PR Newswire - August 30, 2006 - Atrium Medical Corporation Receives FDA Approval for a New Vascular Implant Technology - FLIXENE(TM).
PR Newswire - April 24, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning